Skip to main content
NNNN logo
NNNN
(NASDAQ)
Anbio Biotechnology
$9.74-- (--)
Loading... - Market loading

Anbio Biotechnology (NNNN) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Anbio Biotechnology
NNNNNasdaq Stock MarketHealthcareMedical Instruments & Supplies

About Anbio Biotechnology

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
Share ClassClass A Shares

Contact Information

Phone49 698 7003 9170
Address
Friedrich-Ebert-Anlage 35-37 Frankfurt am Main, 60327 Germany

Corporate Identifiers

CIK0001982708
CUSIPG0367B105
ISINKYG0367B1059
SIC2835

Leadership Team & Key Executives

Michael Lau M.B.A., Ph.D.
Chief Executive Officer
Suki Song CPA
Chief Financial Officer
Chris Tian
Chief Business Officer